Anti-CDK4/6 Fails to Top Chemo in HR-Positive MBC


<![CDATA[]]>(MedPage Today) — SAN ANTONIO — Two chemotherapy-free combinations failed to outperform chemotherapy for slowing hormone receptor (HR)-positive metastatic breast cancer (MBC) that progressed on an aromatase inhibitor (AI), results… Source link